Stay updated on Sitravatinib in Hepatic Impairment Clinical Trial
Sign up to get notified when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.

Latest updates to the Sitravatinib in Hepatic Impairment Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0 on the page.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check57 days agoChange DetectedRevision tag updated from v3.4.1 to v3.4.2.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page shows a revision update from v3.4.0 to v3.4.1; core study details and content remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a Show glossary toggle and updated study record metadata with a new 'Last Update Submitted that Met QC Criteria' field, capitalization changes to 'No FEAR Act Data', and a version bump to v3.4.0 (from v3.3.4).SummaryDifference0.2%

- Check86 days agoChange DetectedRevision label in the page footer updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check107 days agoChange DetectedAdded a consolidated Locations section and removed state-specific location entries (California, Florida, Minnesota, Texas) as part of a revision, and removed the HHS Vulnerability Disclosure link.SummaryDifference0.6%

Stay in the know with updates to Sitravatinib in Hepatic Impairment Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitravatinib in Hepatic Impairment Clinical Trial page.